Diffusion tensor imaging in dementia with Lewy bodies and Alzheimer's disease

Psychiatry Research - Neuroimaging

Volumn 155, Issue 2, 2007, Pages 135-145

  Firbank, Michael J ^a   Blamire, Andrew M ^b   Krishnan, Mani S ^a   Teodorczuk, Andrew ^a   English, Philip ^c   Gholkar, Anil ^c   Harrison, Roger M ^c   O'Brien, John T ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; Dementia with Lewy bodies; Diffusion Tensor Imaging; MRI

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ANISOTROPY; ARTICLE; BRAIN DYSFUNCTION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DEMENTIA; DIFFUSION COEFFICIENT; DIFFUSION TENSOR IMAGING; FEMALE; HUMAN; LEWY BODY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PRIORITY JOURNAL; TEMPORAL LOBE; TISSUE INJURY;

AGED; ALZHEIMER DISEASE; ANISOTROPY; BRAIN; BRAIN MAPPING; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEWY BODY DISEASE; MALE; NEURAL PATHWAYS; PARIETAL LOBE; TEMPORAL LOBE;

EID: 34249915533     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2007.01.001     Document Type: Article

References (32)

1. Alexopoulos G.S., Abrams R.C., Young R.C., and Shamoian C.A. Cornell scale for depression in dementia. Biological Psychiatry 23 (1988) 271-284
2. Bammer R., and Fazekas F. Diffusion imaging in multiple sclerosis. Neuroimaging Clinics of North America 12 1 (2002) 71-106
3. Barber R., Scheltens P., Gholkar A., Ballard C., McKeith I.G., Ince P., Perry R.H., and O'Brien J.T. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. Journal of Neurology, Neurosurgery and Psychiatry 67 (1999) 66-72
4. Bhagat Y.A., and Beaulieu C. Diffusion anisotropy in subcortical white matter and cortical gray matter: changes with aging and the role of CSF-suppression. Journal of Magnetic Resonance Imaging 20 (2004) 216-227
5. Bozzali M., Falini A., Franceschi M., Cercignani M., Zuffi M., Scotti G., Comi G., and Filippi M. White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. Journal of Neurology, Neurosurgery and Psychiatry 72 6 (2002) 742-746
6. Bozzali M., Falini A., Cercignani M., Baglio F., Farina E., Alberoni M., Vezzulli P., Olivotto F., Mantovani F., Shallice T., Scotti G., Canal N., and Nemni R. Brain tissue damage in dementia with Lewy bodies: an in vivo diffusion tensor MRI study. Brain 128 7 (2005) 1595-1604
7. Bozzao A., Floris R., Baviera M.E., Apruzzese A., and Simonetti G. Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load. American Journal of Neuroradiology 22 (2001) 1030-1036
8. Catani M., Jones D.K., Donato R., and Ffytche D.H. Occipito-temporal connections in the human brain. Brain 126 (2003) 2093-2107
9. Cavanna A.E., and Trimble M.R. The precuneus: a review of its functional antatomy and behavioural correlates. Brain 129 (2006) 564-583
10. Colloby S.J., Fenwick J.D., Williams E.D., Paling S.M., Lobotesis K., Ballard C., McKeith I.G., and O'Brien J.T. A comparison of Tc-99m-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. European Journal Of Nuclear Medicine And Molecular Imaging 29 5 (2002) 615-622
11. Cummings J.L., Mega M., Gray K., Rosenberg-Thompson S., Carusi D.A., and Gornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44 12 (1994) 2308-2314
12. DeLano M.C., and Cao Y. High b value diffusion imaging. Neuroimaging Clinics of North America 12 1 (2002) 21-34
13. Duan J.H., Wang H.Q., Xu J., Lin X., Chen S.Q., Kang Z., and Yao Z.B. White matter damage of patients with Alzheimer's disease correlated with the decreased cognitive function. Surgical and Radiologic Anatomy 28 2 (2006) 150-156
14. Fahn S., and Elton R. Members of the UPDRS development committee: unified Parkinson's disease rating scale. In: Fahn S., Marsden C.D., Calne D.B., and Goldstein M. (Eds). Recent developments in Parkinson's disease (1987), MacMillan Healthcare Information, Florham Park; NJ
15. Firbank M.J., Colloby S.J., Burn D.J., McKeith I.G., and O'Brien J.T. Regional cerebral blood flow in Parkinson's with and without dementia. Neuroimage 20 2 (2003) 1309-1319
16. Firbank M.J., Minett T., and O'Brien J.T. Changes in DWI and MRS associated with white matter hyperintensities in elderly subjects. Neurology 61 7 (2003) 950-954
17. Head D., Buckner R.L., Shimony J.S., Williams L.E., Akbudak E., Conturo T.E., McAvoy M., Morris J.C., and Snyder A.Z. Differential vulnerability of anterior white matter in nondemented aging with minimal acceleration in dementia of the Alzheimer type: evidence from diffusion tensor imaging. Cerebral Cortex 14 4 (2004) 410-423
18. Kantarci K., Jack C.R., Xu Y., Campeau N.G., O'Brien P.C., Smith G.E., Ivnik R.J., Boeve B.F., Kokmen E., Tangalos E.G., and Petersen R.C. Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. Radiology 219 1 (2001) 101-107
19. Kantarci K., Xu Y., Shiung M.M., O'Brien P.C., Cha R.H., Smith G.E., Ivnik R.J., Boeve B.F., Edland S.D., Kokmen E., Tangalos E.G., Petersen R.C., and Jack C.R. Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 14 (2002) 198-207
20. Lancaster J.L., Woldorff M.G., Parsons L.M., Liotti M., Freitas C.S., Rainey L., Kochunov P.V., Nickerson D., Mikiten S.A., and Fox P.T. Automated Talairach Atlas labels for functional brain mapping. Human Brain Mapping 10 (2000) 120-131
21. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., Salmon D.P., Lowe J., Mirra S.S., Byrne E.J., Lennox G., Quinn N.P., Edwardson J.A., Ince P.G., Bergeron C., Burns A., Miller B.L., Lovestone S., Collerton D., Jansen E.N.H., Ballard C., deVos R.A.I., Wilcock G.K., Jellinger K.A., and Perry R.H. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 47 5 (1996) 1113-1124
22. McKeith I.G., Ballard C.G., Perry R.H., Ince P.G., O'Brien J.T., Neill D., Lowery K., Jaros E., Barber R., Thompson P., Swann A., Fairbairn A.F., and Perry E.K. Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 54 5 (2000) 1050-1058
23. McKeith I., Mintzer J., Aarsland D., Burn D., Chiu H., Cohen-Mansfield J., Dickson D., Dubois B., Duda J.E., Feldman H., Gauthier S., Halliday G., Lawlor B., Lippa C., Lopez O.L., Carlos Machado J., O'Brien J., Playfer J., Reid W., and International Psychogeriatric association expert meeting on DLB. Dementia with Lewy bodies. Lancet Neurology 3 1 (2004) 19-28
24. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34 (1984) 939-944
25. Medina D., deToledo-Morrell L., Urresta F., Gabrieli J.D., Moseley M., Fleischman D., Bennett D.A., Leurgans S., Turner D.A., and Stebbins G.T. White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study. Neurobiology of Aging 27 5 (2006) 663-672
26. Mori S., Wakana S., Nagae-Poetscher L.M., and van Zijl P.C.M. MRI atlas of human anatomy (2005), Elsevier, Amsterdam
27. Pasquier J., Michel B.F., Brenot-Rossi I., Hassan-Sebbag N., Sauvan R., and Gastaut J.L. Value of Tc99 m-ECD SPET for the diagnosis of dementia with Lewy bodies. European Journal Of Nuclear Medicine And Molecular Imaging 29 10 (2002) 1342-1348
28. Roth M., Tym E., Mountjoy C.Q., Huppert F.A., Hendrie H., Verma S., and Goddard R. CAMDEX - A Standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. British Journal of Psychiatry 149 (1986) 698-709
29. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E.J., Johansen-Berg H., Bannister P.R., De Luca M., Drobnjak I., Flitney D.E., Niazy R., Saunders J., Vickers J., Zhang Y., De Stefano N., Brady J.M., and Matthews P.M. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23 S1 (2004) 208-219
30. van Laere K., Santens P., Bosman T., de Reuck J., Mortelmans L., and Dierckx R. Statistical parametric mapping of 99mTc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters. Journal of Nuclear Medicine 45 6 (2004) 933-942
31. Walker M.P., Ayre G.A., Cummings J.L., Wesnes K., McKeith I.G., O'Brien J.T., and Ballard C.G. The clinician assessment of fluctuation and the one day fluctuation assessment scale. British Journal of Psychiatry 177 (2000) 252-256
32. Yoshiura T., Mihara F., Tanaka A., Ogomori K., Ohyagi Y., Taniwaki T., Yamada T., Yamasaki T., Ichimiya A., Kinukawa N., Kuwabara Y., and Honda H. High b value diffusion weighted imaging is more sensitive to white matter degeneration in Alzheimer's disease. Neuroimage 20 1 (2003) 413-419